142 related articles for article (PubMed ID: 38007172)
1. Examining the impact of immunosuppressive drugs on antibody-dependent cellular cytotoxicity (ADCC) of human peripheral blood natural killer (NK) cells and gamma delta (γδ) T cells.
Jalali S; Stankovic S; Westall GP; Reading PC; Sullivan LC; Brooks AG
Transpl Immunol; 2024 Feb; 82():101962. PubMed ID: 38007172
[TBL] [Abstract][Full Text] [Related]
2. Regulation of anti-HLA antibody-dependent natural killer cell activation by immunosuppressive agents.
Shin BH; Ge S; Mirocha J; Karasyov A; Vo A; Jordan SC; Toyoda M
Transplantation; 2014 Feb; 97(3):294-300. PubMed ID: 24342979
[TBL] [Abstract][Full Text] [Related]
3. Limited efficacy of immunosuppressive drugs on CD8+ T cell-mediated and natural killer cell-mediated lysis of human renal tubular epithelial cells.
Demmers MW; Korevaar SS; Betjes MG; Weimar W; Rowshani AT; Baan CC
Transplantation; 2014 Jun; 97(11):1110-8. PubMed ID: 24704664
[TBL] [Abstract][Full Text] [Related]
4. Impact of commonly used transplant immunosuppressive drugs on human NK cell function is dependent upon stimulation condition.
Meehan AC; Mifsud NA; Nguyen TH; Levvey BJ; Snell GI; Kotsimbos TC; Westall GP
PLoS One; 2013; 8(3):e60144. PubMed ID: 23555904
[TBL] [Abstract][Full Text] [Related]
5. The engagement of CTLA-4 on primary melanoma cell lines induces antibody-dependent cellular cytotoxicity and TNF-α production.
Laurent S; Queirolo P; Boero S; Salvi S; Piccioli P; Boccardo S; Minghelli S; Morabito A; Fontana V; Pietra G; Carrega P; Ferrari N; Tosetti F; Chang LJ; Mingari MC; Ferlazzo G; Poggi A; Pistillo MP
J Transl Med; 2013 May; 11():108. PubMed ID: 23634660
[TBL] [Abstract][Full Text] [Related]
6. In vitro analysis of the proliferative capacity and cytotoxic effects of ex vivo induced natural killer cells, cytokine-induced killer cells, and gamma-delta T cells.
Niu C; Jin H; Li M; Xu J; Xu D; Hu J; He H; Li W; Cui J
BMC Immunol; 2015 Oct; 16():61. PubMed ID: 26458364
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis C virus-induced NK cell activation causes metzincin-mediated CD16 cleavage and impaired antibody-dependent cytotoxicity.
Oliviero B; Mantovani S; Varchetta S; Mele D; Grossi G; Ludovisi S; Nuti E; Rossello A; Mondelli MU
J Hepatol; 2017 Jun; 66(6):1130-1137. PubMed ID: 28192188
[TBL] [Abstract][Full Text] [Related]
8. Within peripheral blood mononuclear cells, antibody-dependent cellular cytotoxicity of rituximab-opsonized Daudi cells is promoted by NK cells and inhibited by monocytes due to shaving.
Beum PV; Lindorfer MA; Taylor RP
J Immunol; 2008 Aug; 181(4):2916-24. PubMed ID: 18684983
[TBL] [Abstract][Full Text] [Related]
9. T cells, particularly activated CD4
Wang Z; Chimenti MS; Strouse C; Weiner GJ
Cancer Immunol Immunother; 2022 Feb; 71(2):237-249. PubMed ID: 34110453
[TBL] [Abstract][Full Text] [Related]
10. A rapid method for assessment of natural killer cell function after multiple receptor crosslinking.
Al-Hubeshy ZB; Coleman A; Nelson M; Goodier MR
J Immunol Methods; 2011 Mar; 366(1-2):52-9. PubMed ID: 21281644
[TBL] [Abstract][Full Text] [Related]
11. IFN-α augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
Tomescu C; Tebas P; Montaner LJ
AIDS; 2017 Mar; 31(5):613-622. PubMed ID: 28225449
[TBL] [Abstract][Full Text] [Related]
12. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effects of NK cells and anti-PD-L1 antibody with antibody-dependent cellular cytotoxicity in PD-L1-positive cancer cell lines.
Park JE; Kim SE; Keam B; Park HR; Kim S; Kim M; Kim TM; Doh J; Kim DW; Heo DS
J Immunother Cancer; 2020 Aug; 8(2):. PubMed ID: 32830112
[TBL] [Abstract][Full Text] [Related]
14. Natural Killer (NK) Cell Education Differentially Influences HIV Antibody-Dependent NK Cell Activation and Antibody-Dependent Cellular Cytotoxicity.
Bernard NF; Kiani Z; Tremblay-McLean A; Kant SA; Leeks CE; Dupuy FP
Front Immunol; 2017; 8():1033. PubMed ID: 28883824
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
Gan X; Zhang L; Solomon GF; Bonavida B
Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
[TBL] [Abstract][Full Text] [Related]
16. Differences in Type 1 and Type 2 intracytoplasmic cytokines, detected by flow cytometry, according to immunosuppression (cyclosporine A vs. tacrolimus) in stable renal allograft recipients.
Rostaing L; Puyoo O; Tkaczuk J; Peres C; Rouzaud A; Cisterne JM; de Preval C; Ohayon E; Durand D; Abbal M
Clin Transplant; 1999 Oct; 13(5):400-9. PubMed ID: 10515221
[TBL] [Abstract][Full Text] [Related]
17. BOS Is Associated With Decreased SIRT1 in Peripheral Blood Proinflammatory T, NK, and NKT-like Lymphocytes.
Hodge G; Hodge S; Liu H; Nguyen P; Holmes-Liew CL; Holmes M
Transplantation; 2019 Nov; 103(11):2255-2263. PubMed ID: 31651733
[TBL] [Abstract][Full Text] [Related]
18. Cetuximab therapy in head and neck cancer: immune modulation with interleukin-12 and other natural killer cell-activating cytokines.
Luedke E; Jaime-Ramirez AC; Bhave N; Roda J; Choudhary MM; Kumar B; Teknos TN; Carson WE
Surgery; 2012 Sep; 152(3):431-40. PubMed ID: 22770960
[TBL] [Abstract][Full Text] [Related]
19. Renal transplant immunosuppression impairs natural killer cell function in vitro and in vivo.
Morteau O; Blundell S; Chakera A; Bennett S; Christou CM; Mason PD; Cornall RJ; O'Callaghan CA
PLoS One; 2010 Oct; 5(10):e13294. PubMed ID: 20967261
[TBL] [Abstract][Full Text] [Related]
20. Effects of cryopreservation on effector cells for antibody dependent cell-mediated cytotoxicity (ADCC) and natural killer (NK) cell activity in (51)Cr-release and CD107a assays.
Mata MM; Mahmood F; Sowell RT; Baum LL
J Immunol Methods; 2014 Apr; 406():1-9. PubMed ID: 24561308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
